Global Thyroid Disorders Market is Expected to Grow at a CAGR of 3.1% by 2022

Global Thyroid Disorder Market Information, by Treatment (drugs and supplements, diagnostics and surgery), by Disease Indication (hypothyroidism, hyperthyroidism and other), by Route of Administration (oral, injectable and others) and by End Users (hospitals and home use) – Forecast till 2022

Global Thyroid Disorder Market Information, by Treatment (drugs and supplements, diagnostics and surgery), by Disease Indication (hypothyroidism, hyperthyroidism and other), by Route of Administration (oral, injectable and others) and by End Users (hospitals and home use) – Forecast till 2022

Thyroid gland produce the hormones namely triiodothyronine (T3) and thyroxine (T4) by trapping iodine from food. These hormones play an important role in the regulation of metabolism, growth & development, intelligence and nervous deficit, fertility, kidney functions, cardiac functions etc. The lack of iodine results in cretinism, goiter, deficient mental development and host of other ailments such as cardiac disorders. According to the international thyroid society almost 20 million Americans suffer from some form of thyroid disease and more than 12 percent of the U.S. population will develop a thyroid condition during their lifetime.

The market driving factors for the world thyroid disorder market are growing prevalence of thyroid disorders, good reimbursement options for treatment and increasing awareness about the implications of thyroid disorders. The rise in screening for iodine disorders and thyroid tumors is also leading to the growth of the market. Growth in risk factors such as obesity, diabetes and auto immune diseases etc. are increasing the number of patients who are suffering from thyroid disorders. For example, diabetics are twice more likely to develop hashimoto’s thyroiditis. Increasing focus of governments especially of developing regions on the healthcare sector and is another driver for the global thyroid disorders market.

Request for sample report at https://www.marketresearchfuture.com/sample_request/2747 .

The market’s restraints includes high costs of the treatment and side-effects associated with current medication. Thyroid disorders treatment medication have a low therapeutic index which is the difference between safe and effective dose. The rise of alternative medicines has also reduced the market size. The market is an extremely consolidated market with few large players dominating it. The thyroid disorder market also reflects an oligopolistic nature in the drugs and supplements segment with a few molecules such as levothyroxine, cytomel, liothyronine, imidazole and propacil dominating the market.

The global thyroid disorders market has been evaluated to be a growing market and it is expected that the market will touch moderate growth figures by growing at a CAGR of 3.1% in future. The major participants of this market are namely Allergan, Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., RLC LABS, AbbVie, Mylan and others.

Depending on the geographic region, thyroid disorders market is segmented into four key regions namely America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for thyroid disorders followed by Europe. Asia Pacific region is expected to be fastest growing region in thyroid disorders market due to increasing investments in the healthcare sector,  increasing awareness about thyroid disorders, its medication as well as screening. 

Browse complete report at https://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747 .

Intended Audience

  • Thyroid diagnostic and surgical manufacturers
  • Anti-thyroid disorder drugs suppliers
  • Private research laboratories
  • Research and development (R&D) companies
  • Market research and consulting service providers
  • Government research laboratories
  • Contract manufacturing organizations 

Key Players for Global Thyroid Disorder Market:

  • Allergan
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • RLC LABS
  • AbbVie
  • Mylan

Request for Discount  https://www.marketresearchfuture.com/check-discount/2747

The report for global thyroid disorder market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the global thyroid market’s segments and regions.

List of Tables

TABLE 1    GLOBAL THYROID DISORDERS MARKET, 2013-2022 (USD MILLION)

TABLE 2    GLOBAL THYROID DISORDERS MARKET, BY DRUG CLASS, 2013-2022 (USD MILLION)

TABLE 3    GLOBAL THYROID DISORDERS MARKET, BY ROUTE OF ADMINISTRATION, 2013-2022 (USD MILLION)

TABLE 4        GLOBAL THYROID DISORDERS MARKET, BY End Users, 2013-2022 (USD MILLION)

TABLE 5    GLOBAL THYROID DISORDERS MARKET, BY REGION, 2013-2022 (USD MILLION)

List of Figures

FIGURE 1    RESEARCH PROCESS

FIGURE 2    PORTERS FIVE FORCES MODEL

FIGURE 3    GLOBAL THYROID DISORDERS MARKET, BY DRUG CLASS

FIGURE 4    GLOBAL THYROID DISORDERS MARKET, BY ROUTE OF ADMINISTRATION

FIGURE 5    GLOBAL THYROID DISORDERS MARKET, BY End Users

FIGURE 6    GLOBAL THYROID DISORDERS MARKET, BY REGION

FIGURE 7    GLOBAL THYROID DISORDERS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)    

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747